山西医药杂志
山西醫藥雜誌
산서의약잡지
SHANXI MEDICAL JOURNAL
2014年
17期
1995-1998
,共4页
刘兵%丁炎%葛鑫%聂宏光%崔湧
劉兵%丁炎%葛鑫%聶宏光%崔湧
류병%정염%갈흠%섭굉광%최용
咪达唑仑%钠通道%短路电流%蛋白磷酸化
咪達唑崙%鈉通道%短路電流%蛋白燐痠化
미체서륜%납통도%단로전류%단백린산화
Midazolam%Sodium channel%Short-circuit currents%Protein phosphorylation
目的:探讨咪达唑仑对人肺上皮细胞短路电流的影响,并探讨可能的机制。方法应用尤斯灌流室装置测定H441单层细胞的短路电流。由总电流减去阿米洛利可抑制的电流算得阿米洛利敏感性电流,以用药前H441单层细胞的阿米洛利敏感性电流初始值为100%对照。用100μmol/L咪达唑仑处理 H441细胞,在0,15,30,60 min 4个时间点提取蛋白用于蛋白印迹法,研究咪达唑仑对细胞外调节蛋白酶(ERK )1/2蛋白磷酸化的影响。结果咪达唑仑能够剂量依赖性抑制 H441单层细胞的短路电流,此电流可被阿米洛利抑制;蛋白印迹法结果显示咪达唑仑能够促进ERK1/2蛋白磷酸化。结论咪达唑仑通过抑制人肺上皮细胞阿米洛利敏感性电流而降低肺泡上皮离子转运,其机制可能与其促进ERK1/2蛋白磷酸化有关。临床上对伴有肺水肿的患者应用咪达唑仑时应考虑其可能对肺泡上皮液体清除的影响。
目的:探討咪達唑崙對人肺上皮細胞短路電流的影響,併探討可能的機製。方法應用尤斯灌流室裝置測定H441單層細胞的短路電流。由總電流減去阿米洛利可抑製的電流算得阿米洛利敏感性電流,以用藥前H441單層細胞的阿米洛利敏感性電流初始值為100%對照。用100μmol/L咪達唑崙處理 H441細胞,在0,15,30,60 min 4箇時間點提取蛋白用于蛋白印跡法,研究咪達唑崙對細胞外調節蛋白酶(ERK )1/2蛋白燐痠化的影響。結果咪達唑崙能夠劑量依賴性抑製 H441單層細胞的短路電流,此電流可被阿米洛利抑製;蛋白印跡法結果顯示咪達唑崙能夠促進ERK1/2蛋白燐痠化。結論咪達唑崙通過抑製人肺上皮細胞阿米洛利敏感性電流而降低肺泡上皮離子轉運,其機製可能與其促進ERK1/2蛋白燐痠化有關。臨床上對伴有肺水腫的患者應用咪達唑崙時應攷慮其可能對肺泡上皮液體清除的影響。
목적:탐토미체서륜대인폐상피세포단로전류적영향,병탐토가능적궤제。방법응용우사관류실장치측정H441단층세포적단로전류。유총전류감거아미락리가억제적전류산득아미락리민감성전류,이용약전H441단층세포적아미락리민감성전류초시치위100%대조。용100μmol/L미체서륜처리 H441세포,재0,15,30,60 min 4개시간점제취단백용우단백인적법,연구미체서륜대세포외조절단백매(ERK )1/2단백린산화적영향。결과미체서륜능구제량의뢰성억제 H441단층세포적단로전류,차전류가피아미락리억제;단백인적법결과현시미체서륜능구촉진ERK1/2단백린산화。결론미체서륜통과억제인폐상피세포아미락리민감성전류이강저폐포상피리자전운,기궤제가능여기촉진ERK1/2단백린산화유관。림상상대반유폐수종적환자응용미체서륜시응고필기가능대폐포상피액체청제적영향。
Objective To explore the effects of midazolam on the short-circuit currents in human alveolar epithelial monolayers and study the possible mechanisms .Methods Short-circuit currents were recorded by us-sing-chamber setup .Amiloride-sensitive currents are defined as the difference between the total current and the amiloride-resistant current .ERK1/2 phosphorylation protein levels are analyzed at 0 ,15 ,30 and 60 min after ad-ministration of 100 μmol/L midazolam .Results Midazolam can inhibit the short-circuit currents in H441 mono-layers dose-dependently ,which can be inhibited by amiloride .Western-blotting analysis shows that midazolam can increase the level of ERK1/2 phosphorylation .Conclusion These data demonstrate that midazolam can reduce the alveolar ion transport by inhibiting the amiloride-sensitive currents ,possibly by the enhancement of ERK1/2 phos-phorylation .The effects of alveolar fluid clearance following application of midazolam should be considered clini-cally when the patient is complicated with lung injury .